Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1834

1.

Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.

Hamauchi S, Yokota T, Mizumachi T, Onozawa Y, Ogawa H, Onoe T, Kamijo T, Iida Y, Nishimura T, Onitsuka T, Yasui H, Homma A.

Int J Clin Oncol. 2019 Jan 17. doi: 10.1007/s10147-018-01392-9. [Epub ahead of print]

PMID:
30656463
2.

Ultrasound-guided placement of a midline catheter in a patient with extensive postburn contractures: A Case report.

Yokota T, Tokumine J, Lefor AK, Hasegawa A, Yorozu T, Asao T.

Medicine (Baltimore). 2019 Jan;98(3):e14208. doi: 10.1097/MD.0000000000014208.

3.

Thrombotic microangiopathy during the fetal period.

Ishimori S, Ohyama S, Yokota T, Morisawa T, Yonetani M.

Pediatr Int. 2018 Jul;60(7):675-676. doi: 10.1111/ped.13596. No abstract available.

PMID:
30648352
4.

Vitamin C and vitamin E double-deficiency increased neuroinflammation and impaired conditioned fear memory.

Takahashi K, Yanai S, Takisawa S, Kono N, Arai H, Nishida Y, Yokota T, Endo S, Ishigami A.

Arch Biochem Biophys. 2019 Jan 8;663:120-128. doi: 10.1016/j.abb.2019.01.003. [Epub ahead of print]

PMID:
30629958
5.

Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: Current Status of Therapeutic Approaches.

Shimizu-Motohashi Y, Komaki H, Motohashi N, Takeda S, Yokota T, Aoki Y.

J Pers Med. 2019 Jan 7;9(1). pii: E1. doi: 10.3390/jpm9010001. Review.

6.

Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies.

Saito Y, Yokota T, Arai M, Tada Y, Sumitani M.

J Pain Res. 2018 Dec 24;12:127-138. doi: 10.2147/JPR.S175900. eCollection 2019.

7.

Remarkable improvement in progressive multifocal leukoencephalopathy following acute pyelonephritis with bacteremia.

Amano E, Ozaki K, Ishibashi S, Sanjo N, Yokota T.

J Clin Neurosci. 2019 Jan 3. pii: S0967-5868(18)31938-6. doi: 10.1016/j.jocn.2018.12.034. [Epub ahead of print]

PMID:
30612916
8.

Ultrasoft electronics to monitor dynamically pulsing cardiomyocytes.

Lee S, Sasaki D, Kim D, Mori M, Yokota T, Lee H, Park S, Fukuda K, Sekino M, Matsuura K, Shimizu T, Someya T.

Nat Nanotechnol. 2018 Dec 31. doi: 10.1038/s41565-018-0331-8. [Epub ahead of print]

PMID:
30598525
9.

Resistance training with interval blood flow restriction effectively enhances intramuscular metabolic stress with less ischemic duration and discomfort.

Okita K, Takada S, Morita N, Takahashi M, Hirabayashi K, Yokota T, Kinugawa S.

Appl Physiol Nutr Metab. 2018 Dec 19. doi: 10.1139/apnm-2018-0321. [Epub ahead of print]

PMID:
30566362
10.

Clinical characteristics and short-term outcomes in patients with acute cholecystitis over aged >80 years.

Akasu T, Kinoshita A, Imai N, Hirose Y, Yamaguchi R, Yokota T, Iwaku A, Koike K, Saruta M.

Geriatr Gerontol Int. 2018 Dec 14. doi: 10.1111/ggi.13588. [Epub ahead of print]

PMID:
30549172
11.

Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges.

Echigoya Y, Lim KRQ, Nakamura A, Yokota T.

J Pers Med. 2018 Dec 7;8(4). pii: E41. doi: 10.3390/jpm8040041. Review.

12.

Impact of admission liver stiffness on long-term clinical outcomes in patients with acute decompensated heart failure.

Omote K, Nagai T, Asakawa N, Kamiya K, Tokuda Y, Aikawa T, Fukushima A, Noguchi K, Kato Y, Komoriyama H, Nishida M, Kudo Y, Iwano H, Yokota T, Anzai T.

Heart Vessels. 2018 Dec 6. doi: 10.1007/s00380-018-1318-y. [Epub ahead of print]

PMID:
30523443
13.

Intermediate-term outcomes of our original multiple-knot technique using ePTFE sutures for anterior mitral leaflet prolapse.

Maeda S, Funatsu T, Kondoh H, Shibukawa T, Yokota T, Kainuma S, Toda K, Sawa Y, Taniguchi K.

Surg Today. 2018 Dec 6. doi: 10.1007/s00595-018-1745-5. [Epub ahead of print]

PMID:
30523410
14.

Two cases of late-onset neuromyelitis optica spectrum disorder initially presenting with isolated cerebral white matter lesions.

Otani T, Irioka T, Takahashi YK, Soga K, Igarashi S, Kaneko K, Takahashi T, Yokota T.

eNeurologicalSci. 2018 Nov 19;13:35-37. doi: 10.1016/j.ensci.2018.11.008. eCollection 2018 Dec. No abstract available.

15.

A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy.

Sanjo N, Nose Y, Shishido-Hara Y, Mizutani S, Sekijima Y, Aizawa H, Tanizawa T, Yokota T.

J Neurol. 2018 Dec 3. doi: 10.1007/s00415-018-9140-0. [Epub ahead of print]

PMID:
30511098
16.

Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy.

Lim KRQ, Yoon C, Yokota T.

J Pers Med. 2018 Nov 24;8(4). pii: E38. doi: 10.3390/jpm8040038. Review.

17.

Addition of melphalan to fludarabine/busulfan (FLU/BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation/peripheral blood stem-cell transplantation.

Ueda T, Maeda T, Kusakabe S, Fujita J, Fukushima K, Yokota T, Shibayama H, Tomiyama Y, Kanakura Y.

Int J Hematol. 2018 Nov 17. doi: 10.1007/s12185-018-2562-8. [Epub ahead of print]

PMID:
30448938
18.

Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates.

Lim KRQ, Echigoya Y, Nagata T, Kuraoka M, Kobayashi M, Aoki Y, Partridge T, Maruyama R, Takeda S, Yokota T.

Mol Ther. 2019 Jan 2;27(1):76-86. doi: 10.1016/j.ymthe.2018.10.011. Epub 2018 Oct 19.

PMID:
30448197
19.

Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy.

Lee JJA, Maruyama R, Duddy W, Sakurai H, Yokota T.

Mol Ther Nucleic Acids. 2018 Dec 7;13:596-604. doi: 10.1016/j.omtn.2018.10.004. Epub 2018 Oct 11.

20.

Overexpression of the vascular brassinosteroid receptor BRL3 confers drought resistance without penalizing plant growth.

Fàbregas N, Lozano-Elena F, Blasco-Escámez D, Tohge T, Martínez-Andújar C, Albacete A, Osorio S, Bustamante M, Riechmann JL, Nomura T, Yokota T, Conesa A, Alfocea FP, Fernie AR, Caño-Delgado AI.

Nat Commun. 2018 Nov 8;9(1):4680. doi: 10.1038/s41467-018-06861-3.

21.

Specific amyloid-β42 deposition in the brain of a Gerstmann-Sträussler-Scheinker disease patient with a P105L mutation on the prion protein gene.

Furukawa F, Sanjo N, Kobayashi A, Hamaguchi T, Yamada M, Kitamoto T, Mizusawa H, Yokota T.

Prion. 2018;12(5-6):315-319. doi: 10.1080/19336896.2018.1541689. Epub 2018 Nov 13.

PMID:
30394185
22.

Dual-gate organic phototransistor with high-gain and linear photoresponse.

Chow PCY, Matsuhisa N, Zalar P, Koizumi M, Yokota T, Someya T.

Nat Commun. 2018 Oct 31;9(1):4546. doi: 10.1038/s41467-018-06907-6.

23.

Brain-Derived Neurotrophic Factor Improves Limited Exercise Capacity in Mice With Heart Failure.

Matsumoto J, Takada S, Kinugawa S, Furihata T, Nambu H, Kakutani N, Tsuda M, Fukushima A, Yokota T, Tanaka S, Takahashi H, Watanabe M, Hatakeyama S, Matsumoto M, Nakayama KI, Otsuka Y, Sabe H, Tsutsui H, Anzai T.

Circulation. 2018 Oct 30;138(18):2064-2066. doi: 10.1161/CIRCULATIONAHA.118.035212. No abstract available.

PMID:
30372141
24.

Nonthrombogenic, stretchable, active multielectrode array for electroanatomical mapping.

Lee W, Kobayashi S, Nagase M, Jimbo Y, Saito I, Inoue Y, Yambe T, Sekino M, Malliaras GG, Yokota T, Tanaka M, Someya T.

Sci Adv. 2018 Oct 19;4(10):eaau2426. doi: 10.1126/sciadv.aau2426. eCollection 2018 Oct.

25.

Bilateral Optic Tract Hyperintensity due to Pituitary Apoplexy.

Hirata K, Numasawa Y, Kobayashi Z, Yokota T.

Intern Med. 2018 Oct 17. doi: 10.2169/internalmedicine.1515-18. [Epub ahead of print] No abstract available.

26.

Prasugrel versus clopidogrel for residual thrombus burden in patients with ST-segment elevation myocardial infarction: an optical coherence tomography study.

Yokota T, Higuma T, Endo T, Nishizaki F, Hanada K, Yokoyama H, Yamada M, Okumura K, Tomita H.

Coron Artery Dis. 2018 Dec;29(8):663-669. doi: 10.1097/MCA.0000000000000663.

PMID:
30308586
27.

Self-powered ultra-flexible electronics via nano-grating-patterned organic photovoltaics.

Park S, Heo SW, Lee W, Inoue D, Jiang Z, Yu K, Jinno H, Hashizume D, Sekino M, Yokota T, Fukuda K, Tajima K, Someya T.

Nature. 2018 Sep;561(7724):516-521. doi: 10.1038/s41586-018-0536-x. Epub 2018 Sep 26.

PMID:
30258137
28.

Super-Resolution of Magnetic Resonance Images via Convex Optimization with Local and Global Prior Regularization and Spectrum Fitting.

Kawamura N, Yokota T, Hontani H.

Int J Biomed Imaging. 2018 Sep 2;2018:9262847. doi: 10.1155/2018/9262847. eCollection 2018.

29.

[A Case of Advanced Gastric Cancer with Bladder Metastasis].

Sato N, Kinoshita A, Imai N, Kinoshita Y, Hirose Y, Shibata K, Yamaguchi R, Akasu T, Yokota T, Iwaku A, Kijima N, Koike K, Saruta M.

Gan To Kagaku Ryoho. 2018 Sep;45(9):1361-1363. Japanese.

PMID:
30237382
30.

Conversion surgery with gemcitabine plus nab-paclitaxel for locally advanced unresectable pancreatic cancer: A case report.

Okura R, Takano S, Yokota T, Yoshitomi H, Kagawa S, Furukawa K, Takayashiki T, Kuboki S, Suzuki D, Sakai N, Nojima H, Mishima T, Miyazaki M, Ohtsuka M.

Mol Clin Oncol. 2018 Oct;9(4):389-393. doi: 10.3892/mco.2018.1688. Epub 2018 Aug 1.

31.

Nerve conduction study of the association between glycemic variability and diabetes neuropathy.

Akaza M, Akaza I, Kanouchi T, Sasano T, Sumi Y, Yokota T.

Diabetol Metab Syndr. 2018 Sep 12;10:69. doi: 10.1186/s13098-018-0371-0. eCollection 2018.

32.

"Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic.

Gordish-Dressman H, Willmann R, Dalle Pazze L, Kreibich A, van Putten M, Heydemann A, Bogdanik L, Lutz C, Davies K, Demonbruen AR, Duan D, Elsey D, Fukada SI, Girgenrath M, Patrick Gonzalez J, Grounds MD, Nichols A, Partridge T, Passini M, Sanarica F, Schnell FJ, Wells DJ, Yokota T, Young CS, Zhong Z, Spurney C, Spencer M, De Luca A, Nagaraju K, Aartsma-Rus A.

J Neuromuscul Dis. 2018;5(4):407-417. doi: 10.3233/JND-180324.

33.

Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.

Zenda S, Yamaguchi T, Yokota T, Miyaji T, Mashiko T, Tanaka M, Yonemura M, Takeno M, Okano T, Kawasaki T, Nakamori Y, Ishii S, Shimada S, Kanamaru M, Uchitomi Y.

BMC Cancer. 2018 Sep 6;18(1):873. doi: 10.1186/s12885-018-4763-1.

34.

Impact of High Respiratory Exchange Ratio During Submaximal Exercise on Adverse Clinical Outcome in Heart Failure.

Kakutani N, Fukushima A, Yokota T, Katayama T, Nambu H, Shirakawa R, Maekawa S, Abe T, Takada S, Furihata T, Ono K, Okita K, Kinugawa S, Anzai T.

Circ J. 2018 Oct 25;82(11):2753-2760. doi: 10.1253/circj.CJ-18-0103. Epub 2018 Aug 31.

35.

Exon Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy.

Hara Y, Mizobe Y, Miyatake S, Takizawa H, Nagata T, Yokota T, Takeda S, Aoki Y.

Methods Mol Biol. 2018;1828:553-564. doi: 10.1007/978-1-4939-8651-4_36.

PMID:
30171567
36.

Morpholino-Mediated Exon Skipping Targeting Human ACVR1/ALK2 for Fibrodysplasia Ossificans Progressiva.

Maruyama R, Yokota T.

Methods Mol Biol. 2018;1828:497-502. doi: 10.1007/978-1-4939-8651-4_32.

PMID:
30171563
37.

Systemic and ICV Injections of Antisense Oligos into SMA Mice and Evaluation.

Aslesh T, Maruyama R, Yokota T.

Methods Mol Biol. 2018;1828:455-465. doi: 10.1007/978-1-4939-8651-4_28.

PMID:
30171559
38.

In Vitro Evaluation of Antisense-Mediated Exon Inclusion for Spinal Muscular Atrophy.

Touznik A, Maruyama R, Yokota T.

Methods Mol Biol. 2018;1828:439-454. doi: 10.1007/978-1-4939-8651-4_27.

PMID:
30171558
39.

In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.

Maruyama R, Aoki Y, Takeda S, Yokota T.

Methods Mol Biol. 2018;1828:365-379. doi: 10.1007/978-1-4939-8651-4_23.

PMID:
30171554
40.

In Vivo Evaluation of Single-Exon and Multiexon Skipping in mdx52 Mice.

Mizobe Y, Miyatake S, Takizawa H, Hara Y, Yokota T, Nakamura A, Takeda S, Aoki Y.

Methods Mol Biol. 2018;1828:275-292. doi: 10.1007/978-1-4939-8651-4_17.

PMID:
30171548
41.

Systemic Injection of Peptide-PMOs into Humanized DMD Mice and Evaluation by RT-PCR and ELISA.

Melo D, Maruyama R, Yokota T.

Methods Mol Biol. 2018;1828:263-273. doi: 10.1007/978-1-4939-8651-4_16.

PMID:
30171547
42.

Creation of DMD Muscle Cell Model Using CRISPR-Cas9 Genome Editing to Test the Efficacy of Antisense-Mediated Exon Skipping.

Maruyama R, Yokota T.

Methods Mol Biol. 2018;1828:165-171. doi: 10.1007/978-1-4939-8651-4_10.

PMID:
30171541
43.

In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.

Nakamura A, Aoki Y, Tsoumpra M, Yokota T, Takeda S.

Methods Mol Biol. 2018;1828:151-163. doi: 10.1007/978-1-4939-8651-4_9.

PMID:
30171540
44.
45.

Quantitative Evaluation of Exon Skipping in Immortalized Muscle Cells In Vitro.

Lim KRQ, Yokota T.

Methods Mol Biol. 2018;1828:127-139. doi: 10.1007/978-1-4939-8651-4_7.

PMID:
30171538
46.

Tips to Design Effective Splice-Switching Antisense Oligonucleotides for Exon Skipping and Exon Inclusion.

Maruyama R, Yokota T.

Methods Mol Biol. 2018;1828:79-90. doi: 10.1007/978-1-4939-8651-4_5.

PMID:
30171536
47.

Nusinersen in the Treatment of Spinal Muscular Atrophy.

Goodkey K, Aslesh T, Maruyama R, Yokota T.

Methods Mol Biol. 2018;1828:69-76. doi: 10.1007/978-1-4939-8651-4_4.

PMID:
30171535
48.

Recent Advances and Clinical Applications of Exon Inclusion for Spinal Muscular Atrophy.

Son HW, Yokota T.

Methods Mol Biol. 2018;1828:57-68. doi: 10.1007/978-1-4939-8651-4_3.

PMID:
30171534
49.
50.

Invention and Early History of Exon Skipping and Splice Modulation.

Lim KRQ, Yokota T.

Methods Mol Biol. 2018;1828:3-30. doi: 10.1007/978-1-4939-8651-4_1.

PMID:
30171532

Supplemental Content

Loading ...
Support Center